vs
Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.6%).
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
IVT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.4M | $75.5M |
| Net Profit | $2.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -11.0% | 22.7% |
| Net Margin | 3.4% | — |
| Revenue YoY | 8.6% | 27.7% |
| Net Profit YoY | -72.8% | — |
| EPS (diluted) | $0.02 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $77.4M | $75.5M | ||
| Q3 25 | $74.5M | $54.5M | ||
| Q2 25 | $73.6M | $52.4M | ||
| Q1 25 | $73.8M | $46.0M | ||
| Q4 24 | $71.2M | $59.1M | ||
| Q3 24 | $68.5M | $80.5M | ||
| Q2 24 | $67.4M | $47.1M | ||
| Q1 24 | $66.8M | $43.8M |
| Q4 25 | $2.7M | — | ||
| Q3 25 | $6.0M | $8.8M | ||
| Q2 25 | $95.9M | $5.9M | ||
| Q1 25 | $6.8M | $3.0M | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-539.0K | $20.3M | ||
| Q2 24 | $1.5M | $-4.5M | ||
| Q1 24 | $2.9M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -11.0% | 22.7% | ||
| Q3 25 | -9.8% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | -10.5% | 8.7% | ||
| Q4 24 | -3.6% | 22.6% | ||
| Q3 24 | -18.7% | 27.4% | ||
| Q2 24 | -13.6% | -4.6% | ||
| Q1 24 | -13.1% | -5.3% |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 8.1% | 16.2% | ||
| Q2 25 | 130.4% | 11.2% | ||
| Q1 25 | 9.2% | 6.5% | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | -0.8% | 25.2% | ||
| Q2 24 | 2.2% | -9.6% | ||
| Q1 24 | 4.3% | -11.0% |
| Q4 25 | $0.02 | $0.26 | ||
| Q3 25 | $0.08 | $0.17 | ||
| Q2 25 | $1.23 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $-0.01 | $0.41 | ||
| Q2 24 | $0.02 | $-0.09 | ||
| Q1 24 | $0.04 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $825.9M | $22.7M |
| Stockholders' EquityBook value | $1.8B | $130.3M |
| Total Assets | $2.8B | $216.3M |
| Debt / EquityLower = less leverage | 0.46× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $825.9M | $22.7M | ||
| Q3 25 | $764.6M | $34.0M | ||
| Q2 25 | $746.3M | $45.3M | ||
| Q1 25 | $740.7M | $56.7M | ||
| Q4 24 | $740.4M | $68.0M | ||
| Q3 24 | $740.1M | $79.3M | ||
| Q2 24 | $812.2M | $90.7M | ||
| Q1 24 | $827.5M | $102.0M |
| Q4 25 | $1.8B | $130.3M | ||
| Q3 25 | $1.8B | $115.3M | ||
| Q2 25 | $1.8B | $104.7M | ||
| Q1 25 | $1.7B | $97.1M | ||
| Q4 24 | $1.8B | $92.1M | ||
| Q3 24 | $1.8B | $71.1M | ||
| Q2 24 | $1.5B | $48.5M | ||
| Q1 24 | $1.5B | $51.0M |
| Q4 25 | $2.8B | $216.3M | ||
| Q3 25 | $2.7B | $202.9M | ||
| Q2 25 | $2.7B | $194.9M | ||
| Q1 25 | $2.6B | $196.2M | ||
| Q4 24 | $2.6B | $213.3M | ||
| Q3 24 | $2.6B | $220.7M | ||
| Q2 24 | $2.5B | $205.0M | ||
| Q1 24 | $2.5B | $214.1M |
| Q4 25 | 0.46× | 0.17× | ||
| Q3 25 | 0.42× | 0.30× | ||
| Q2 25 | 0.41× | 0.43× | ||
| Q1 25 | 0.42× | 0.58× | ||
| Q4 24 | 0.42× | 0.74× | ||
| Q3 24 | 0.42× | 1.12× | ||
| Q2 24 | 0.53× | 1.87× | ||
| Q1 24 | 0.53× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.4M | $14.4M |
| Free Cash FlowOCF − Capex | $110.9M | $14.4M |
| FCF MarginFCF / Revenue | 143.3% | 19.1% |
| Capex IntensityCapex / Revenue | 57.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 58.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $193.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $155.4M | $14.4M | ||
| Q3 25 | $43.8M | $9.7M | ||
| Q2 25 | $48.7M | $14.1M | ||
| Q1 25 | $20.2M | $3.6M | ||
| Q4 24 | $136.9M | $15.6M | ||
| Q3 24 | $38.4M | $11.0M | ||
| Q2 24 | $46.7M | $1.0M | ||
| Q1 24 | $14.8M | $11.2M |
| Q4 25 | $110.9M | $14.4M | ||
| Q3 25 | $31.4M | $9.7M | ||
| Q2 25 | $38.0M | $14.1M | ||
| Q1 25 | $12.8M | $3.6M | ||
| Q4 24 | $100.8M | $15.6M | ||
| Q3 24 | $29.3M | $11.0M | ||
| Q2 24 | $37.2M | $1.0M | ||
| Q1 24 | $7.7M | — |
| Q4 25 | 143.3% | 19.1% | ||
| Q3 25 | 42.2% | 17.7% | ||
| Q2 25 | 51.6% | 26.8% | ||
| Q1 25 | 17.4% | 7.7% | ||
| Q4 24 | 141.5% | 26.4% | ||
| Q3 24 | 42.8% | 13.7% | ||
| Q2 24 | 55.2% | 2.1% | ||
| Q1 24 | 11.5% | — |
| Q4 25 | 57.5% | 0.0% | ||
| Q3 25 | 16.7% | 0.0% | ||
| Q2 25 | 14.6% | 0.0% | ||
| Q1 25 | 10.0% | 0.1% | ||
| Q4 24 | 50.7% | 0.0% | ||
| Q3 24 | 13.3% | 0.0% | ||
| Q2 24 | 14.0% | 0.0% | ||
| Q1 24 | 10.6% | 0.0% |
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | 1.10× | ||
| Q2 25 | 0.51× | 2.41× | ||
| Q1 25 | 2.97× | 1.21× | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 31.15× | — | ||
| Q1 24 | 5.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
